secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001193125-25-132699
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior posts updated corporate presentation June 2025; content not fully disclosed
--------------------------------------------------------------------------------

- Company added 'Corporate Presentation June 2025' to its investor relations website on June 2, 2025.
- Presentation furnished as Exhibit 99.1; full text not provided in SEC filing excerpt.
- No specific financial guidance, clinical data, or operational updates available from truncated exhibit.
- Investors should refer to the full presentation on Indivior's IR page for details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/0001193125-25-132699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/d949841d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-132699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer